10% Owner Lynx1 Capital Management LP acquire 100,000 shares of Tscan Therapeutics Inc [TCRX]
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Tscan Therapeutics Inc’s recent filing unveils that its 10% Owner Lynx1 Capital Management LP acquired Company’s shares for reported $4114.0
Tscan Therapeutics Inc’s filing revealed that its Director Klencke Barbara acquired Company’s shares for reported $26450.0 on Sep 23 ’24.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.